Vanda Pharmaceuticals Inc. Quarterly Amortization of Intangible Assets in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2010 to Q3 2024.
  • Vanda Pharmaceuticals Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $1.75M, a 361% increase year-over-year.
  • Vanda Pharmaceuticals Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $6.47M, a 327% increase year-over-year.
  • Vanda Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2023 was $2.09M, a 37.9% increase from 2022.
  • Vanda Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2022 was $1.52M, a 2.57% increase from 2021.
  • Vanda Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2021 was $1.48M, unchanged from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.47M $1.75M +$1.37M +361% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.1M $1.75M +$1.37M +363% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $3.73M $2.02M +$1.64M +432% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.09M $953K +$574K +151% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-08
Q3 2023 $1.52M $380K +$1K +0.26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.52M $378K -$1K -0.26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.52M $379K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.52M $379K +$10K +2.71% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-08
Q3 2022 $1.51M $379K +$9K +2.43% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.5M $379K +$10K +2.71% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $1.49M $379K +$9K +2.43% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $1.48M $369K -$1K -0.27% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-08
Q3 2021 $1.48M $370K +$1K +0.27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.48M $369K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.48M $370K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $1.48M $370K $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $1.48M $369K -$7K -1.86% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.49M $369K -$10K -2.64% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $1.5M $370K -$10K -2.63% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.51M $370K -$10K -2.63% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.52M $376K -$21K -5.29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.54M $379K -$19K -4.77% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.56M $380K +$28K +7.96% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.53M $380K -$52K -12% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-11
Q3 2018 $1.58M $397K -$35K -8.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.61M $398K -$34K -7.87% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.65M $352K -$102K -22.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $1.75M $432K -$1.67M -79.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $3.42M $432K -$2.51M -85.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $5.93M $432K -$2.51M -85.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $8.44M $454K -$2.49M -84.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $10.9M $2.11M -$838K -28.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q3 2016 $11.8M $2.94M $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $11.8M $2.94M $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $11.8M $2.94M -$1.2M -29% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $13M $2.94M +$2.41M +449% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-15
Q3 2015 $10.6M $2.94M +$2.41M +449% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $8.16M $2.94M +$2.33M +377% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $5.83M $4.14M +$3.58M +633% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $2.25M $536K +$159K +42.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $2.1M $536K +$159K +42.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $1.94M $617K +$245K +65.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $1.69M $565K +$196K +53.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $1.5M $377K $0 0% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-12
Q3 2013 $1.5M $377K $0 0% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-27
Q2 2013 $1.5M $372K $0 0% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $1.5M $369K $0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $1.5M $377K $0 0% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $1.5M $377K $0 0% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $1.5M $372K $0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $1.5M $369K $0 0% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $1.5M $377K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $377K $0 0% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $372K $0 0% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $369K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $377K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $372K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.